Publications - 'C'
Publications 2476 - 2500 de 2875
| Titre | DOI |
|---|---|
|
Cost-analysis of opportunistic influenza vaccination in general medical inpatients D.C. Darmaputra; F.Y. Zaman; Y.Li Khu; V. Nagalingam; D. Liew; A.Kar Aung 2021 |
10.1111/imj.15270 |
|
Cost-Effective CNNs for Real-Time Micro-Expression Recognition R. Belaiche; Y. Liu; C. Migniot; D. Ginhac; F. Yang 2020 |
10.3390/app10144959 |
|
Cost-effectiveness analysis of elbasvir-grazoprevir regimen for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France F. Maunoury; A. Clement; C. Nwankwo; L. Levy-Bachelot; A. Abergel; V. Di Martino; E. Thervet; I. Durand-Zaleski 2018 |
10.1371/journal.pone.0194329 |
|
Cost-effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer R. Pelloux-Prayer; P. Schiele; S. Oudard; G. Gravis; F. Kleinclauss; G. Crehange; C. Hennequin; A.K. Morgans; L. Geoffrois; S. Limat; A. Thiery-Vuillemin; V. Nerich 2021 |
10.1016/j.clgc.2021.03.022 |
|
COST-EFFECTIVENESS ANALYSIS OF INNOVATIVE THERAPY FOR PATIENTS WITH NEWLY DIAGNOSED HORMONE-SENSITIVE METASTATIC PROSTATE CANCER R. Pelloux-Prayer; P. Schiele; S. Oudard; G. Gravis; F. Kleinclauss; G. Crehange; C. Hennequin; A. Morgans; L. Geoffrois; S. Limat; A. Thiery-Vuillemin; V. Nerich 2022 |
|
|
Cost-effectiveness analysis of routine use of eribulin in patients with metastatic breast cancer in France: A retrospective analysis. M.J. Paillard; E. Curtit; V. Nerich; L. Cals; F. Bazan; L. Mansi; N. Meneveau; P. Montcuquet; E. Dobi; L. Chaigneau; H. Almotlak; A. Thiery-Vuillemin; C. Villanueva; X.B. Pivot 2014 |
10.1200/jco.2014.32.15_suppl.e11531 |
|
Cost-effectiveness analysis of stereotactic radiotherapy in colorectal cancer brain metastases A. Paix; F. Thillays; J. Biau; N. Vulquin; I. Pop; K. Debbi; A.L. Grosu; E.A. Sauleau; G. Noel 2019 |
|
|
Cost-effectiveness analysis of stereotactic radiotherapy in melanoma brain metastases. A. Paix; F. Thillays; F. Courtault-Deslandes; I. Pop; J. Biau; O. Briard; A.L. Grosu; E.A. Sauleau; G. Noel 2019 |
10.1016/S0167-8140(19)31286-1 |
|
Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors for Patients with Advanced Gastrointestinal Stromal Tumors V. Nerich; C. Fleck; L. Chaigneau; N. Isambert; C. Borg; E. Kalbacher; M. Jary; P. Simon; X. Pivot; J.Y. Blay; S. Limat 2017 |
10.1007/s40261-016-0463-2 |
|
Cost-effectiveness and clinical outcomes of double versus single cord blood transplantation in adults with acute leukemia in France M. Labopin; A. Ruggeri; N.Claude Gorin; E. Gluckman; D. Blaise; L. Mannone; N. Milpied; I. Yakoub-Agha; E. Deconinck; M. Michallet; N. Fegueux; G. Socie; S. Nguyen; J.Yves Cahn; T. de Revel; F. Garnier; C. Faucher; N. Taright; C. Kenzey; F. Volt; D. Bertrand; M. Mohty; V. Rocha; Eurocord; S.Franaise G. Therapi 2014 |
10.3324/haematol.2013.092254 |
|
Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study N.G. Campos; N. Lince-Deroche; C.J. Chibwesha; C. Firnhaber; J.S. Smith; P. Michelow; G. Meyer-Rath; L. Jamieson; S. Jordaan; M. Sharma; C. Regan; S. Sy; G. Liu; V. Tsu; J. Jeronimo; J.J. Kim 2018 |
10.1097/QAI.0000000000001778 |
|
Cost-effectiveness of diagnostic tests for threatened preterm labor in singleton pregnancy in France T. Desplanches; C. Lejeune; J. Cottenet; P. Sagot; C. Quantin 2018 |
10.1186/s12962-018-0106-y |
|
Cost-effectiveness of elbasvir-grazoprevir association for treating hepatitis C virus genotype 1 infection in stage 4-5 chronic kidney disease patients in France F. Maunoury; A. Clement; E.H. Elbasha; A. Abergel; V. Di Martino; E. Thervet; L. Levy-Bachelot; I. Durand-Zaleski 2017 |
10.1016/S0168-8278(17)30951-0 |
|
Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study S. Loubiere; A. Drezet; M. Beau-Faller; D. Moro-Sibilot; S. Friard; M. Wislez; H. Blons; C. Daniel; V. Westeel; A. Madroszyk; H. Lena; P. Merle; J. Mazieres; G. Zalcman; R. Lacave; M. Antoine; F. Morin; P. Missy; F. Barlesi; P. Auquier; J. Cadranel; F.Corp Thora InterGrp 2018 |
10.1183/13993003.01467-2017 |
|
Cost-effectiveness of telestroke in five organizational scenarios in Franche-Comte (France) B. Bouamra; M. de Bustos; F. Vuillier; P. Montiel; L. Bonnet; T. Moulin 2015 |
|
|
COST-EFFECTIVENESS OF TREATMENT SEQUENCES FOR BRAF WILD-TYPE METASTATIC MELANOMA IN REAL LIFE IN FRANCE M. Kandel; A. Bardet; S. Dalle; L. Mortier; B. Guillot; C. Dutriaux; M.T. Leccia; S. Dalac; H. Montaudie; P. Saiag; D. Legoupil; F. Brunet-Possenti; J.P. Arnault; B. Dreno; C. Allayous; S. Michiels; C. Lebbe; I. Borget 2019 |
|
|
COST-EFFECTIVENESS OF TREATMENT SEQUENCES FOR BRAF WILD-TYPE METASTATIC MELANOMA IN REAL LIFE IN FRANCE M. Kandel; A. Bardet; S. Dalle; L. Mortier; B. Guillot; C. Dutriaux; M.T. Leccia; S. Dalac; H. Montaudie; P. Saiag; D. Legoupil; F. Brunet-Possenti; J.P. Arnault; B. Dreno; C. Allayous; S. Michiels; C. Lebbe; I. Borget 2019 |
|
|
COST-EFFECTIVENESS OF TREATMENT SEQUENCES FOR BRAF-MUTATED METASTATIC MELANOMA PATIENTS IN REAL LIFE IN FRANCE M. Kandel; A. Bardet; S. Dalle; L. Mortier; B. Guillot; C. Dutriaux; M.T. Leccia; S. Dalac; H. Montaudie; P. Saiag; D. Legoupil; F. Brunet-Possenti; J.P. Arnault; B. Dreno; C. Allayous; C. Lebbe; I. Borget 2019 |
|
|
Cost-efficient and high precision method for the assembly of LN-based photonic crystal slabs on the fiber tip for the implementation of E-field sensors B. Robert; V. Calero; M.A. Suarez; R. Salut; F. Behague; F. Baida; N. Courjal; M.P. Bernal 2021 |
10.1364/OME.431142 |
|
Cost-utility analyses of drug therapies in breast cancer: a systematic review V. Nerich; S. Saing; E.Maria Gamper; G. Kemmler; F. Daval; X. Pivot; B. Holzner 2016 |
10.1007/s10549-016-3924-7 |
|
Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study I. Borget; M. Perol; D. Perol; A. Lavole; L. Greillier; P. Do; V. Westeel; J. Crequit; H. Lena; I. Monnet; H. Le Caer; P. Fournel; L. Falchero; M. Poudenx; F. Vaylet; S. Chabaud; A. Vergnenegre; G. Zalcman; C. Chouaid; I.F.C.T.G.F.P.C. Investigators 2014 |
10.1186/1471-2407-14-953 |
|
Cost-utility study of the combination of metformin with the different glucose-lowering medication classes in adults 80 aged and older S. Colombat; M. Boulin 2020 |
10.1016/j.therap.2019.09.002 |
|
Costovertebral arthritis revealing spondyloarthritis D. Wendling; S. Aubry; F. Verhoeven; C. Prati 2019 |
10.1016/j.jbspin.2018.06.005 |
|
Cotrimoxazole as a Treatment for Recurrent Idiopathic Anterior Scleritis: A Single-center Experience in 20 Patients P. Bielefeld; A. Muselier; H. Devilliers; C. Creuzot-Garcher; G. Muller; J.F. Besancenot; A.M. Bron 2015 |
10.3109/09273948.2013.874446 |
|
Could 18-FDG PET/CT radiomics features predict outcomes in locally advanced esophageal cancer? L. Lefebvre; J. Henriques; A. Falcoz; A. Meurisse; G. Crehange; L. Boldrini; N. Dinapoli; D. Vernerey; R. Gatta; B. De Bari 2021 |